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ABSTRACT
Background
Alcohol has been reported to be a common and modifiable risk factor for hypertension.
However, observational studies are subject to confounding by other behavioural and
sociodemographic factors, while clinical trials are difficult to implement and have limited
follow-up time. Mendelian randomization can provide robust evidence on the nature of this
association by use of a common polymorphism in aldehyde dehydrogenase 2 (ALDH2)a sa
surrogate for measuring alcohol consumption. ALDH2 encodes a major enzyme involved in
alcohol metabolism. Individuals homozygous for the null variant (*2*2) experience adverse
symptoms when drinking alcohol and consequently drink considerably less alcohol than wild-
type homozygotes (*1*1) or heterozygotes. We hypothesise that this polymorphism may
influence the risk of hypertension by affecting alcohol drinking behaviour.
Methods and Findings
We carried out fixed effect meta-analyses of the ALDH2 genotype with blood pressure (five
studies, n ¼ 7,658) and hypertension (three studies, n ¼ 4,219) using studies identified via
systematic review. In males, we obtained an overall odds ratio of 2.42 (95% confidence interval
[CI] 1.66–3.55, p¼4.8310
 6) for hypertension comparing *1*1 with *2*2 homozygotes and an
odds ratio of 1.72 (95% CI 1.17–2.52, p ¼ 0.006) comparing heterozygotes (surrogate for
moderate drinkers) with *2*2 homozygotes. Systolic blood pressure was 7.44 mmHg (95% CI
5.39–9.49, p¼1.1310
 12) greater among *1*1 than among *2*2 homozygotes, and 4.24 mmHg
(95% CI 2.18–6.31, p¼0.00005) greater among heterozygotes than among *2*2 homozygotes.
Conclusions
These findings support the hypothesis that alcohol intake has a marked effect on blood
pressure and the risk of hypertension.
The Editors’ Summary of this article follows the references.
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Observational epidemiological studies have generally re-
ported that blood pressure is lower among individuals with a
moderate alcohol intake than in nondrinkers, but that heavy
alcohol intake is associated with an increase in blood pressure
[1–4]. However, associations in observational studies of
alcohol intake and blood pressure may be heavily confounded
by factors such as diet, smoking, exercise levels, and socio-
economic position. Conversely, the detection of high blood
pressure may lead to efforts to reduce alcohol intake, which
will attenuate any positive association. In addition, reporting
of alcohol is likely to be subject to considerable error, and
this error may be differential—e.g., people who have been
advised to reduce alcohol intake for medical reasons may
under-report alcohol intake.
Randomized controlled trials in which individuals are
randomized to drink different amounts of alcohol are
problematic for ethical reasons and in terms of compliance,
so trials have generally randomized individuals who drink at
least moderate amounts of alcohol to receive interventions
aimed at reducing drinking. It is difﬁcult to know how
successful such interventions are, and how taking part in a
trial aimed at reducing alcohol intake inﬂuences reporting of
(rather than actual) drinking behaviour. Furthermore, follow-
up is generally short-term, whereas alcohol intake may have
long-term effects on blood pressure.
Mendelian randomization can provide robust evidence on
such associations [5]. Alcohol is initially metabolised to an
intermediate compound, acetaldehyde, which is further
metabolised and then eliminated from the body. The major
enzyme responsible for the elimination of acetaldehyde is
alcohol dehydrogenase 2 (ALDH2) [6]. In some populations,
the ALDH2 gene is polymorphic and an individual’s genotype
at this locus inﬂuences blood acetaldehyde concentrations
after drinking [7]. A single point mutation in ALDH2 has
resulted in the ALDH2*2 allele, which is common in some
Asian populations. The resultant protein has an amino acid
substitution from glutamic acid (glutamate) to lysine at
residue 487, and an inactive subunit. This substitution leads
to an inability to metabolize acetaldehyde and causes an
accumulation of acetaldehyde after alcohol intake [7].
Individuals who are homozygous for the ALDH2*2 allele have
18 times higher, and heterozygotes have ﬁve times higher,
peak blood acetaldehyde levels compared with *1*1 homo-
zygotes (wild type) [8]. ALDH2*2*2 homozygotes are charac-
terized by a facial ﬂushing response after consumption of
alcohol coupled with nausea, drowsiness, headache, and other
unpleasant symptoms that normally prevent them from heavy
drinking [8]. Heterozygotes have a limited ability to metab-
olize acetaldehyde, but exhibit a less severe reaction than that
seen among ALDH2*2*2 homozygotes. Due to the above
adverse symptoms when drinking alcohol, *2*2 homozygotes
drink considerably less alcohol than people homozygous for
the wild-type allele (*1), with heterozygotes drinking inter-
mediate amounts [9]. The genetic variant is not, however,
associated with factors that would confound the relationship
of alcohol consumption and blood pressure (such as smoking)
nor, of course, would germline genetic variants be inﬂuenced
by blood pressure level. Thus genotype can deﬁne groups
with considerably different levels of lifetime average alcohol
intake but with no difference in confounding factors and
without the inﬂuence of reverse causation or differential
reporting bias. Analysing individuals by genotype is akin to a
randomised controlled trial of different levels of alcohol
intake. This approach has been used to provide proof of
concept—the genotype related to higher alcohol intake is also
associated with the predicted increase in oesophageal cancer
risk, a disease generally considered to be alcohol related [9].
We have used a Mendelian randomization approach [5] to
Figure 1. Flow Diagram Showing Reasons for Exclusion and Number of Papers Excluded
doi:10.1371/journal.pmed.0050052.g001
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Alcohol Consumption and Blood Pressureestablish the extent to which alcohol intake results in changes
in blood pressure, using ALDH2 genotype as an instrument
for indexing alcohol intake at a group level, producing
groups with relatively high (*1*1), moderate (*1*2), and very
low alcohol consumption (*2*2). We undertook a systematic
review and carried out meta-analyses of studies examining
the association of ALDH2 with risk of hypertension and/or
level of blood pressure.
Methods
Search Strategy
Papers included in the systematic review were retrieved
from Medline (http://www.ncbi.nlm.nih.gov/PubMed) and ISI
web of Knowledge (http://wok.mimas.ac.uk/) using the search
terms: ‘‘Aldehyde dehydrogenase 2’’ and ‘‘ALDH2’’ in
combination with ‘‘Hypertension’’, ‘‘Blood pressure’’, ‘‘Car-
diovascular diseases’’, ‘‘Coronary disease’’, ‘‘Heart disease’’,
‘‘Coronary artery disease’’. The bibliographies of retrieved
articles were also scanned for relevant publications. We
searched for all papers published before October 2006.
Screening of studies for inclusion was performed by two
researchers (LC, SJL) independently of each other to increase
objectivity. We also searched for all studies of the ALDH2
genotype regardless of outcome for use in separate analyses,
and we scanned the abstracts of these studies to determine
whether they may include any of the outcomes we were
interested in. If we were uncertain we scanned the paper and
then contacted the authors. There was no exclusion on the
basis of language. For multiple publications based on the
same study, the latest publication was included. For inclusion
we required, as a minimum, data on systolic or diastolic blood
pressure by genotype or prevalence of hypertension by
genotype. Where insufﬁcient data for inclusion were available
in the paper we contacted authors directly, and if sufﬁcient
information could still not be obtained the study was
excluded. A ﬂow diagram showing the number of studies
found in our search strategy, and reasons for exclusion is
given in Figure 1.
Data Extraction
We followed a standard protocol for data extraction. For
each study, the following data were recorded (where
available): ﬁrst author’s name, year of publication, country
and city in which the study was performed, name of the study,
study design, number and source of participants, sex, method
of assessment of drinking status, categories of alcohol
drinking, mean alcohol drinking and standard deviation by
ALDH2 genotype, distribution of potential confounding
factors by genotype with p-values, distribution of genotypes
among hypertensive and nonhypertensive participants, mean
blood pressure and standard deviation by ALDH2 genotype,
and reported effect estimates (i.e., relative risks, odds ratios,
or mean difference of blood pressure level) and 95%
conﬁdence intervals (CIs) for ALDH2 genotype and hyper-
tension risk. Data extraction was carried out by two
researchers (LC, SJL) independently of each other.
Statistical Analysis
Data on alcohol intake were converted to a uniform
measure of grams per day for comparison across all studies
with 1 unit ¼ 10 ml ¼ 7.9 g [10].
T
a
b
l
e
1
.
O
u
t
l
i
n
e
o
f
S
t
u
d
i
e
s
I
n
c
l
u
d
e
d
i
n
t
h
e
M
e
t
a
-
a
n
a
l
y
s
i
s
R
e
f
e
r
e
n
c
e
L
o
c
a
t
i
o
n
P
a
r
t
i
c
i
p
a
n
t
s
N
o
.
o
f
P
a
r
t
i
c
i
p
a
n
t
s
S
e
x
A
g
e
A
l
c
o
h
o
l
S
t
a
t
u
s
O
u
t
c
o
m
e
s
R
e
l
e
v
a
n
t
t
o
H
y
p
e
r
t
e
n
s
i
o
n
O
t
h
e
r
C
o
v
a
r
i
a
t
e
s
A
m
a
m
o
t
o
e
t
a
l
.
,
2
0
0
2
[
1
8
]
A
r
u
r
a
l
f
a
r
m
i
n
g
t
o
w
n
n
e
a
r
K
y
o
t
o
,
J
a
p
a
n
L
o
c
a
l
r
e
s
i
d
e
n
t
s
u
n
d
e
r
l
i
n
g
m
e
d
i
c
a
l
c
h
e
c
k
-
u
p
2
,
0
3
5
M
i
x
e
d
5
8
.
0
(
M
)
;
5
6
.
3
(
F
)
B
y
g
e
n
o
t
y
p
e
D
B
P
;
h
y
p
e
r
t
e
n
s
i
o
n
;
S
B
P
S
e
x
;
a
g
e
;
s
m
o
k
i
n
g
;
B
M
I
H
a
s
h
i
m
o
t
o
e
t
a
l
.
,
2
0
0
2
[
1
3
]
T
o
k
y
o
,
J
a
p
a
n
H
o
s
p
i
t
a
l
e
m
p
l
o
y
e
e
s
1
3
3
M
a
l
e
4
6
.
0
6
6
.
9
(
c
a
s
e
)
;
4
8
.
0
6
7
.
3
(
c
o
n
t
r
o
l
)
B
y
g
e
n
o
t
y
p
e
D
B
P
;
S
B
P
A
g
e
;
B
M
I
;
s
m
o
k
i
n
g
;
e
x
e
r
c
i
s
e
l
e
v
e
l
I
w
a
i
e
t
a
l
.
,
2
0
0
4
[
3
1
]
S
u
i
t
a
,
J
a
p
a
n
M
u
n
i
c
i
p
a
l
p
o
p
u
l
a
t
i
o
n
r
e
g
i
s
t
r
y
1
,
8
4
9
M
i
x
e
d
3
0
–
7
9
;
6
6
.
3
1
6
1
1
.
0
5
(
M
)
;
6
3
.
3
3
6
1
1
.
0
2
(
F
)
B
y
g
e
n
o
t
y
p
e
H
y
p
e
r
t
e
n
s
i
o
n
S
e
x
M
a
c
k
e
n
z
i
e
e
t
a
l
.
,
2
0
0
5
[
1
2
]
U
K
C
o
m
m
u
n
i
t
y
-
b
a
s
e
d
v
o
l
u
n
t
e
e
r
r
e
g
i
s
t
e
r
2
8
M
i
x
e
d
3
1
6
1
0
(
c
a
s
e
)
;
3
0
6
7
(
c
o
n
t
r
o
l
_
1
)
;
2
9
6
5
(
c
o
n
t
r
o
l
_
2
)
B
y
g
e
n
o
t
y
p
e
S
B
P
,
D
B
P
S
e
x
,
a
g
e
,
B
M
I
N
i
s
h
i
m
u
r
a
e
t
a
l
.
,
2
0
0
2
[
1
1
]
3
4
J
a
p
a
n
e
s
e
,
1
A
m
e
r
i
c
a
n
,
a
n
d
1
V
i
e
t
n
a
m
e
s
e
H
e
a
l
t
h
y
p
e
o
p
l
e
3
6
M
i
x
e
d
2
2
 
1
6
3
 
3
(
*
1
*
1
)
;
2
3
 
1
6
3
 
4
(
*
1
*
2
/
*
2
*
2
)
N
o
D
B
P
;
S
B
P
A
g
e
O
k
a
y
a
m
a
e
t
a
l
.
,
1
9
9
4
[
1
4
]
O
t
s
u
,
J
a
p
a
n
F
a
c
t
o
r
y
w
o
r
k
e
r
1
5
9
M
a
l
e
4
5
.
6
;
2
1
–
6
2
B
y
g
e
n
o
t
y
p
e
D
B
P
;
S
B
P
A
g
e
;
B
M
I
S
a
i
t
o
e
t
a
l
.
,
2
0
0
3
[
2
8
]
S
h
i
s
o
,
J
a
p
a
n
L
o
c
a
l
p
o
p
u
l
a
t
i
o
n
3
3
5
M
a
l
e
4
0
–
6
9
B
y
g
e
n
o
t
y
p
e
H
y
p
e
r
t
e
n
s
i
o
n
;
D
B
P
;
S
B
P
A
g
e
;
B
M
I
;
s
m
o
k
i
n
g
;
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
T
a
k
a
g
i
e
t
a
l
.
,
2
0
0
1
[
1
9
]
S
u
i
t
a
,
J
a
p
a
n
M
u
n
i
c
i
p
a
l
p
o
p
u
l
a
t
i
o
n
r
e
g
i
s
t
r
y
4
,
0
5
7
M
i
x
e
d
3
0
–
7
9
B
y
g
e
n
o
t
y
p
e
D
B
P
;
S
B
P
S
e
x
;
a
g
e
;
B
M
I
;
s
m
o
k
i
n
g
T
s
u
r
i
t
a
n
i
e
t
a
l
.
,
1
9
9
5
[
2
0
]
K
a
n
a
z
a
w
a
,
J
a
p
a
n
J
a
p
a
n
e
s
e
W
o
r
k
e
r
s
h
e
a
l
t
h
c
h
e
c
k
-
u
p
4
0
3
M
a
l
e
3
5
–
6
1
B
y
g
e
n
o
t
y
p
e
D
B
P
;
S
B
P
A
g
e
;
B
M
I
Y
a
m
a
d
a
e
t
a
l
.
,
2
0
0
2
[
2
9
]
I
s
h
i
k
a
w
a
,
J
a
p
a
n
W
o
r
k
e
r
s
f
r
o
m
e
l
e
c
t
r
o
n
i
c
p
a
r
t
s
-
p
r
o
d
u
c
i
n
g
f
a
c
t
o
r
y
8
2
8
M
a
l
e
4
3
.
1
6
6
.
4
;
3
5
–
5
9
B
y
g
e
n
o
t
y
p
e
S
B
P
;
D
B
P
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
m
e
d
.
0
0
5
0
0
5
2
.
t
0
0
1
PLoS Medicine | www.plosmedicine.org March 2008 | Volume 5 | Issue 3 | e52 0463
Alcohol Consumption and Blood PressureWe calculated the unadjusted mean difference in blood
pressure or the odds ratio of hypertension by comparing
*1*2 and *1*1 to *2*2 genotypes. In the analyses of
hypertension, ﬁxed-effects meta-analysis was used to calcu-
late summary odds ratio estimates, and in the analyses of
diastolic and systolic blood pressure, mean differences
between genotype groups were obtained. We carried out
ﬁxed-effects meta-analyses separately for men and women,
excluding two very small studies (Nishimura [11], n ¼ 36, and
Mackenzie [12], n¼28) that did not provide data separately by
sex, and two further small studies [13,14] for which we were
unable to obtain estimates of blood pressure separately for
*1*2 and *2*2 genotypes. All statistical analyses were carried
out with the use of Stata statistical software (version 9.2; Stata
Corporation). All statistical tests were two-sided. We assessed
evidence of small-study effects (which may include publica-
tion bias) for studies of ALDH2 polymorphism and hyper-
tension risk, and for ALDH2 and blood pressure by
computing both the Egger [15] and Begg [16] tests.
For the studies that reported both blood pressure and
mean alcohol intake by genotype, we calculated estimates of
the causal effect of alcohol on blood pressure, using the
method of instrumental variables with genotype as the
instrument assuming the effect is linear. In order to use
standard instrumental variable estimation methods (‘two-
stage least squares’) [17] the corr2data command in Stata was
used to construct an artiﬁcial dataset matching the reported
number of participants with each genotype, and the means
and standard deviations of alcohol intake and blood pressure
within each genotype. One study reported the mean but not
the standard deviation of alcohol intake by genotype [18], so
it was estimated from a histogram. As the correlation between
alcohol intake and blood pressure within each genotype was
not available, this correlation was assumed to be zero, which
is slightly conservative, as the standard error of the estimated
effect of alcohol on blood pressure reduces slightly as this
correlation increases. As a sensitivity analysis we repeated the
analysis assuming a correlation of 0.2 in all genotypes and all
studies. Instrument strength was assessed using the ﬁrst-stage
F-statistic; values considerably above 10 are generally taken to
show sufﬁcient instrument strength to ensure the validity of
two-stage least-squares [17]. The resulting estimates were then
meta-analysed using the same methods as above.
Results
Table 1 provides details of the studies identiﬁed in our
systematic review and included in our meta-analysis. The
systematic review identiﬁed ten articles reporting on associ-
ations between ALDH2 and hypertension or blood pressure,
the majority of which were cross sectional studies; ﬁve of
these studies focused on male populations only (Table 1). All
studies were population-based and the majority of partic-
ipants were Japanese except one very small study carried out
in the UK [12]. Tables 2 and 3 show associations between
genotype and alcohol intake, and between genotype and
potential confounders, with p-values taken from the original
papers. All studies showed substantial differences in alcohol
intake by genotype among men; among women alcohol intake
was very low, but studies showed trends in the same direction
as men. Whilst it is not possible to combine data on alcohol
intake by genotype across all studies due to inconsistent and
incomplete reporting of data, the two largest studies [18,19]
that contributed most of the weight to the meta-analysis
showed alcohol intake levels among men were around 20–30
g/d in *1*1 homozygotes, 10–15 g/d in heterozygotes and 0–2
g/d in *2*2 homozygotes. Table 3 shows that ALDH2 genotype
was not consistently or strongly associated with sex, smoking,
or physical activity, although there were minor differences in
BMI in men but not women in the two largest studies [18,19].
Meta-analysis with hypertension as the outcome included
4,219 participants from three publications. In males, the
pooled odds ratio was 2.42 (95% CI 1.66–3.55, p ¼ 4.8 3 10
 6)
Table 2. The Distribution of Alcohol Intake by Genotype in the Studies Included in This Meta-analysis
Data Type Reference No. of
Participants
Alcohol Exposure Groups,
Grams of Ethanol per Day
Sex Alcohol Status by Genotype
a
*1*1 *1*2 *2*2
Categorical data Saito et al., 2003 [28] 335 ,18.6 Male 39 87 21
18.6–37 54 33 0
 37.1 81 15 0
Ex-drinker 3 1 0
Yamada et al., 2002 [29] 828 Nondrinker Male 21 56 28
,2.26 75 86 16
2.27–47.4 114 75 2
47.5–71.1 210 64 2
.71.1 63 16 0
Continuous data Amamoto et al., 2002 [18] 2,035 N/D Male 26.3 15.5 0.66
N/D Female 1.4 0.5 0.03
Hashimoto et al., 2002 [13] 133 N/D Male 54.9 6 13.1 51 6 9.8 —
Mackenzie et al., 2005 [12] 28 N/D Mixed 23.7 6 39.5 31.6 6 39.5 —
Okayama et al., 1994 [14] 159 N/D Male 26.8 6 19.1 17.6 6 17.9 —
Takagi et al., 2001 [19] 4,057 N/D Male 23.7 6 16.7 11.5 6 15.8 1.1 6 16.9
N/D Female 3.8 6 6.0 1.2 6 6.8 0.08 6 6.5
Tsuritani et al., 1995 [20] 403 N/D Male 42.7 6 28.8 22.9 6 25.1 2.4 6 3.6
aAlcohol status is presented by genotype: n for categorical data and mean 6 standard deviation for continuous data (10 ml alcohol ¼ 7.9 g).
N/D: not done/no data.
doi:10.1371/journal.pmed.0050052.t002
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Alcohol Consumption and Blood Pressurefor *1*1 versus *2*2 and 1.72 (95% CI 1.17–2.52, p ¼ 0.006)
(Figure 2). No association between ALDH2 and hypertension
was found in females, for whom drinking levels in any
genotype group were low.
Meta-analyses of diastolic blood pressure (DBP) and systolic
blood pressure (SBP) were performed on 7,658 participants
from ﬁve publications. Results were similar to the meta-
analysis of hypertension, with mean differences in blood
pressure by ALDH2 genotype being observed in males only
(Figure 3). Mean DBP in males with the *1*1 genotype was
3.95 mmHg higher than among *2*2 homozygotes (95% CI
2.66–5.24, p ¼ 1.78 3 10
 9), while among heterozygotes mean
DBP was 1.58 mmHg higher than among *2*2 homozygotes
(95% CI 0.29–2.87, p ¼ 0.016). A similar result was obtained
for SBP, with a mean difference of 7.44 mmHg (95% CI 5.39–
9.49, p ¼ 1.1 3 10
 12) between *1*1 and *2*2 homozygotes,
and a mean difference of 4.24 mmHg (95% CI 2.18–6.31, p ¼
0.00005) between heterozygotes and *2*2 homozygotes.
There was no strong evidence of heterogeneity between the
studies. In the meta-analysis of hypertension comparing *1*2
heterozygotes and *1*1 homozygotes there was some evi-
dence that effect sizes were greater in smaller studies (Begg’s
test p ¼ 0.12; Egger’s test p ¼ 0.05). A small-study effect was
also detected in the analysis of male DBP differences between
ALDH2 genotypes (DBP: *1*1 versus *2*2 Begg’s test p¼0.05;
Egger’s test p ¼ 0.04), no other associations showed evidence
of small study bias. Sensitivity analysis including only studies
with more than 500 individuals gave the following results:
Table 3. Distribution of Potential Confounding Factors by Genotype among Studies Included in the Meta-analysis
Author No. of
Participants
Covariates Category Covariates by Genotypes
a Published
p-Values
b
*1*1 *1*2 *2*2
Amamoto et al., 2002 [18] 2,035 Sex Male 335 (44.7) 351 (46 9) 63 (8.4) —
Female 644 (50.1) 555 (43.2) 87 (6.8) —
Age Male 56.8 6 15.7 58.1 6 15.6 52.8 6 17.7 0.05
Female 54.8 6 16.0 55.1 6 15.4 58.5 6 14.3 0.12
BMI Male 22.9 6 3.0 22.3 6 2.8 21.9 6 2.7 0.004
Female 22.5 6 3.1 22.4 6 3.3 22.4 6 3.1 0.89
Current smoker Male 176 (52.5) 173 (49.3) 36 (56.5) 0.49
Female 39 (6.1) 48 (8.6) 9 (10.5) 0.16
Cigarette smoking,
cigarettes per day
Male 10.4 10.8 11.5 0.78
Female 0.69 1.04 1.02 0.17
Hashimoto et al., 2002 [13] 133 Age — 46.0 6 7.1 46.2 6 5.8 — .0.05
BMI — 22.5 6 2.0 22.2 6 1.6 — .0.05
Smoking, cigarettes
per day
— 14.2 6 16.3 12.7 6 13.8 — .0.05
Exercise, times per
month
—2 . 6 6 3.1 2.6 6 2.7 — .0.05
Iwai et al., 2004 [31] 1,849 Sex Male 443 (51.6) 348 (40.6) 67 (7 8) —
Female 520 (52.3) 381 (38.3) 93 (9 4) —
Mackenzie et al., 2005 [12] 28 Sex Male 8 (47.1) 9 (52.9) — —
Age Female 9 (81.8) 2 (18.2) — —
—3 0 6 7 (12); 29 6 5 (5) 31 6 10 — —
BMI — 23.8 6 3.1(12); 22.0 6 3.4 (5) 23.0 6 3.1 — —
Nishimura et al., 2002 [11] 36 Age — 22.1 6 3.3 23.1 6 3.4 — —
Okayama et al., 1994 [14] 159 Age — 45.7 6 10.2 48.0 6 9.4 — —
BMI — 22.9 6 2.8 21.8 6 2.7 — —
Saito et al., 2003 [28] 335 Age — 53.3 6 8.6 53.4 6 8.8 52.4 6 8.4 0.89
BMI — 23.5 6 3.0 23.3 6 3.1 23.0 6 2.5 0.71
Smoking Current smokers 100 (56.3) 77 (55.9) 14 (66. 7) 0.12
Never-smokers 49 (27.8) 25 (18.4) 4 (19.1)
Ex-smokers 28 (15.9) 35 (25.7) 3 (14.3)
Physical activity Inactive 66 (37.5) 52 (38.2) 3 (14.3) 0.32
Moderate 50 (28.4) 41 (30.2) 8 (38.1)
Active 60 (34.1) 43 (31.6) 10 (47.6)
Takagi et al., 2001 [19] 4,057 Sex Male 924 (48.2) 825 (43.0) 170 (8.8) —
Female 1,112 (52.0) 838 (39.2) 188 (8.8) —
Age Male 60.2 6 12.2 61.6 6 11.5 61.3 6 11.7 0.05
Female 58.5 6 13.3 59.6 6 11.6 58. 4 6 12 3 0.09
BMI Male 23.2 6 3.0 22.8 6 2.9 23.1 6 2.6 0.02
Female 22.4 6 3.3 22.1 6 2.9 22.3 6 2.7 0.11
Current smoker Male 367 (39.7) 326 (39.5) 61 (35.9) n.s.
Female 93 (8.4) 68 (8.2) 13 (7.5) n.s.
Tsuritani et al., 1995 [20] 403 Age — 46.4 6 5.8 45.7 6 5.0 46.4 6 4.4 n.s.
BMI — 24.7 6 2.8 24.3 6 3.0 24.9 6 2.4 n.s.
aCovariant status are presented by genotype: n (%) for categorical data and mean 6 standard deviation for continuous data
bp-Values were according to the original report from papers. n.s., reported the result as not significant.
doi:10.1371/journal.pmed.0050052.t003
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Alcohol Consumption and Blood Pressurehypertension *1*1 versus *2*2 OR¼2.23 (95% CI 1.49–3.33; p
¼0.00009), *1*2 versus *2*2 OR¼1.62 (95% CI 1.08–2.42; p¼
0.02); DBP *1*1 versus *2*2 mean difference ¼ 3.48 mmHg
(95% CI 2.07–4.88; p ¼ 1.3 3 10
 6), *1*2 versus *2*2 mean
difference¼1.33 mmHg (95% CI 0.07 to 2.74; p¼0.063) and
SBP *1*1 versus *2*2 mean difference¼6.73 mmHg (95% CI
4.43–9.03; p¼9.7310
 9), *1*2 versus *2*2 mean difference¼
3.78 mmHg (95% CI 1.47–6.09; p ¼ 0.01).
Figure 4 shows the relationship between the genotype means
of alcohol consumption and blood pressure in the three
studies that reported data for both. We see that alcohol intake
level was low among females and that neither alcohol intake
nor blood pressure varied noticeably by genotype. In males
there was clear variation in both and the relationship between
the two appears to be close to linear. The study [20] that
reported greater variation in alcohol intake by genotype than
the other two studies also reported greater variation in blood
pressure, so that the slope of the predicted alcohol–blood
pressure effect appeared similar in all studies. We examined
this relationship more formally using instrumental variables.
The ﬁrst-stage F-statistics ranged from 42 [20] to 1,962 [19],
indicating that genotype is a strong instrument for estimating
alcohol consumption and all three studies are large enough to
ensure the validity of the instrumental variables method used.
The resulting estimates of the effect of alcohol on blood
pressure in males are shown in the forest plot in Figure 5. No
between-study heterogeneity was detected in the effect for
either systolic or diastolic blood pressure, although power to
detect heterogeneity was limited by the small number of
studies. The meta-analytic summary estimate of the effect of
alcohol intake on DBP was 0.16 (95% CI 0.11–0.21) mmHg per
g/d, while the summary estimate of the effect on SBP was
slightly larger at 0.24 (95% CI 0.16–0.32) mmHg per g/d. The
results were essentially unchanged in the sensitivity analysis
that assumed a correlation between alcohol and blood pressure
within each genotype of 0.2 rather than zero: the instrumental
variable estimates for each study were unchanged, while their
standard errors reduced by between 1% and 7%.
Discussion
We carried out a meta-analysis of the association between
the ALDH2 genotype and blood pressure, in which we used
ALDH2 genotype as a marker of differing alcohol intake
levels. We found that individuals with the ALDH2 *1*1
genotype, with average alcohol intakes of 20–30 g/d, had
strikingly higher systolic and diastolic blood pressure than
those with the ALDH*2*2 genotype, who tend to drink only
small amounts of alcohol. In addition, the risk of hyper-
tension among *1*1 homozygotes was around 2.5-fold above
that among *2*2 homozgotes. Even heterozygotes who tended
to be quite modest drinkers had elevated blood pressure and
a 70% increased risk of hypertension compared with
individuals with the *2*2 genotype. Exploratory analyses
using an instrumental variable approach in which the
association between genotype and alcohol intake and the
association between genotype and blood pressure was
triangulated to give an estimate of the effect of alcohol on
blood pressure, we obtained estimates of a 0.24 mmHg
increase in SBP per gram of alcohol per day over the course
of a lifetime (because genotype inﬂuences on alcohol intake
will represent differences that generally persist throughout
adult life).
It is difﬁcult to compare these effects with those seen in
randomized controlled trials, because very few trials have
managed to include a control group drinking little or no
alcohol, and randomized controlled trials look at the effect of
changes in alcohol consumption over a short time period,
whereas genetic variants will inﬂuence alcohol intake over a
lifetime. One very small (n ¼ 10) randomized crossover trial
published in 1986 found that among healthy male volunteers,
7 d abstaining from alcohol was associated with an decrease
in SBP of 3.00 mmHg relative to when drinking 60 g/d [21],
although it should be emphasised that this very small study
examined changes over a short time period.
Studies that have monitored blood pressure after admin-
istration of alcohol have found biphasic effects of alcohol,
with acute vasodilation effects immediately after ingestion
Figure 2. Forest Plot of Studies of ALDH2 Genotype and Hypertension
doi:10.1371/journal.pmed.0050052.g002
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Alcohol Consumption and Blood Pressurefollowed by increases in blood pressure in a dose-dependent
manner [22]. It is not clear how much of this increase is a
short-term transient effect or how this translates into longer-
term effects on blood pressure levels [22]. The recent
suggestion that there is no good evidence that reducing
alcohol intake will reduce blood pressure reﬂects this
uncertainty [23].
Two studies [13,18] included in this review found that body
mass index (BMI) is slightly higher among *1*1 individuals
than among individuals with other genotypes. This effect was
seen among men, but not among women. As alcohol is an
energy-dense macronutrient and has an appetite-enhancing
effect [24], it is likely that the increase in BMI among
individuals with the *1*1 genotype is due to their increased
alcohol consumption. In support of this a positive association
between BMI and alcohol intake has been observed among
men in epidemiological studies [25]. A cohort study carried
out in a Toyama, Japan among factory employees with an age
range of 35 to 59 years found that for each 1 unit increase in
BMI, SBP increased by 0.86 mmHg and DBP increased by 0.69
mmHg [26]. BMI was on average 1 unit higher among
individuals with the *1*1 genotype than among those with
the *2*2 genotype in the study by Amamoto et al. [18]
included in this review. The predicted blood pressure effect
of genotype differences in BMI equates to 11.6% of the
observed difference in SBP and 16.3% of the observed
difference in DBP by genotype. Therefore a small proportion
of the genotype differences in blood pressure in this review
may have occurred through genotype differences in BMI, but
the majority of the effect is likely to be due to independent
effects of alcohol on blood pressure.
It is possible that the ALDH *2*2 genotype inﬂuenced
blood pressure directly or by another mechanism that was
independent of the effect on alcohol intake (pleiotropy).
Figure 3. Forest Plot of Studies of ALDH2 Genotype and Blood Pressure
doi:10.1371/journal.pmed.0050052.g003
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Alcohol Consumption and Blood PressureAnalyses of this genotype in relation to oesophageal cancer
are complicated by dual effects of the ALDH2 *2*2 genotype
in reducing alcohol intake but dramatically increasing
acetaldehyde, a potent carcinogen, among those who do
drink [9]. Elevation of acetaldehyde causes vasodilation, and
consequently lower blood pressure, which is associated with
increased skin temperature and characteristic ﬂushing
observed among ALDH2 *2*2 homozygotes [27]. The lower
blood pressure associated with acetaldehyde could account
for the acute reduction in blood pressure immediately after
ingesting alcohol. However, this effect is short lived, and
acetaldehyde is unlikely to explain the lower blood pressure
seen among *2*2 homozygotes in this study, particularly as
they tend not to drink. In fact, heterozygotes tend to have
higher levels of acetaldehyde than either *1*1 or *2*2
homozygotes, because although they drink alcohol in moder-
ation, they clear acetaldehyde at a much slower rate and
consequently have greater elevations of acetaldehyde per unit
of alcohol consumed than do *1*1 homozygotes, which is
illustrated by their high oesophageal cancer risk relative to
other genotypes [9]. Therefore if the association between
genotype and blood pressure were due to acetaldehyde levels
rather than alcohol intake per se we would expect hetero-
zygote individuals to have the lowest blood pressure and the
lowest risk of hypertension. It is also possible that these
results have arisen by confounding due to close proximity of
the genotype of interest with other genotypes that may
inﬂuence blood pressure (the close proximity of genotypes at
different loci such that they are inherited together is termed
linkage disequilibrium). Evidence that the effects of this
genotype on blood pressure are due to differences in alcohol
consumption levels rather than pleiotropic effects of ALDH2
or linkage disequilibrium, is provided by the data on women,
who tended not to drink and among whom there were no
differences in blood pressure by genotype. If either pleio-
tropic effects or confounding by linkage disequilibrium were
operating, an effect on blood pressure would be seen in both
sexes.
Figure 4. Mean Blood Pressure in Each Genotype Plotted against Mean Alcohol Consumption in Each Genotype in the Three Studies That Gave Data for
Both Relationships
Top graph: systolic blood pressure. Bottom graph: diastolic blood pressure. Larger plotting symbols indicate a greater number of individuals.
doi:10.1371/journal.pmed.0050052.g004
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Alcohol Consumption and Blood PressureAdditional evidence that argues against linkage disequili-
brium and pleiotropic effects and an effect of acetaldehyde
on blood pressure, is that among studies that looked at the
effect of ALDH2 genotype after adjustment or stratiﬁcation
for amount of alcohol consumed there was no difference in
blood pressure by genotype [11,13,14,18,20,28,29]. The excep-
tion is a study that found a residual association between
ALDH2 and blood pressure in a multiple logistic regression
analysis including age, BMI, genotype, and alcohol consump-
tion, but the association with genotype in this analysis was
considerably weaker than in the univariate analysis, and the
authors concluded that this difference could be due to
differences in past drinking habits between genotype groups,
which were not controlled for in the analysis [19]. The ﬁnding
could also be due to measurement error in self-reported
alcohol intake data or chance.
There was some evidence of small-study effects in our
review, which suggests that publication bias may have
occurred. This bias may have led to an overestimation of
the effects in the meta-analyses. However, only three of the
largest studies were included in our instrumental variable
analysis, as these were the only studies that presented mean
alcohol intake by genotype, and so we do not expect this
estimate to be inﬂuenced to a great extent by small-study
bias; in addition a sensitivity analysis including only studies
with at least 500 participants showed only minor changes in
effect estimates.
In summary, observational epidemiological studies have
proved to be a misleading source of knowledge regarding the
cardioprotective effects of several dietary factors [30].
Inadequate statistical control for confounding by other
behavioural and sociodemographic factors related to cardi-
ovascular disease risk are likely to underlie this problem. This
study shows that alcohol intake may increase blood pressure
to a much greater extent, even among moderate drinkers,
than previously thought. Large-scale replication studies are
required to conﬁrm this ﬁnding and to improve the precision
of our estimates.
Supporting Information
Alternative Language Abstract S1. Translation of the Abstract in
Chinese by Lina Chen.
Found at doi:10.1371/journal.pmed.0050052.sd001 (20 KB DOC).
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Alcohol Consumption and Blood PressureEditors’ Summary
Background. High blood pressure (hypertension) is a common medical
condition that affects nearly a third of US and UK adults. Hypertension
has no symptoms but can lead to heart attacks or strokes. It is diagnosed
by measuring blood pressure—the force that blood moving around the
body exerts on the inside of large blood vessels. Blood pressure is
highest when the heart is pumping out blood (systolic pressure) and
lowest when it is filling up with blood (diastolic pressure). Normal blood
pressure is defined as a systolic pressure of less than 130 millimeters of
mercury (mmHg) and a diastolic pressure of less than 85 mmHg (a blood
pressure of 130/85). A reading of more than 140/90 indicates hyper-
tension. Many factors affect blood pressure, but overweight people and
individuals who eat too much salty or fatty foods are at high risk of
developing hypertension. Mild hypertension can often be corrected by
lifestyle changes, but many people also take antihypertensive drugs to
reduce their blood pressure.
Why Was This Study Done? Another modifiable lifestyle factor thought
to affect blood pressure is alcohol intake. Observational studies that ask
people about their drinking habits and measure their blood pressure
suggest that alcohol intake correlates with blood pressure, but they
cannot prove a causal link because of ‘‘confounding’’—other risk factors
associated with alcohol drinking, such as diet, might also affect the study
participant’s blood pressures. A trial that randomly assigns people to
different alcohol intakes could provide this proof of causality, but such a
trial is impractical. In this study, therefore, the researchers have used
‘‘Mendelian randomization’’ to investigate whether alcohol intake affects
blood pressure. An inactive variant of aldehyde dehydrogenase 2
(ALDH2; the enzyme that removes alcohol from the body) has been
identified. People who inherit the variant form of this gene from both
parents have an ALDH2 *2*2 genotype (genetic makeup) and become
flushed and nauseated after drinking. Consequently, they drink less than
people with a *1*2 genotype and much less than those with a *1*1
genotype. Because inheritance of these genetic variants does not affect
lifestyle factors other than alcohol intake, an association between ALDH2
genotypes and blood pressure would indicate that alcohol intake has an
effect on blood pressure without any confounding.
What Did the Researchers Do and Find? The researchers identified ten
published studies (mainly done in Japan where the ALDH2 gene variant is
common) on associations between ALDH2 genotype and blood pressure
or hypertension using a detailed search protocol (a ‘‘systematic review’’).
A meta-analysis (a statistical method for combining the results of
independent studies) of the studies that had investigated the association
between ALDH2 genotype and hypertension showed that men with the
*1*1 genotype (highest alcohol intake) and those with the *1*2 genotype
(intermediate alcohol intake) were 2.42 and 1.72 times more likely,
respectively, to have hypertension than those with the *2*2 genotype
(lowest alcohol intake). There was no association between ALDH2
genotype and hypertension among the women in these studies because
they drank very little. Systolic and diastolic blood pressures showed a
similar relationship to ALDH2 genotype in a second meta-analysis of
relevant studies. Finally, the researchers estimated that for men the
lifetime effect of drinking 1 g of alcohol a day (one unit of alcohol
contains 8 g of alcohol in the UK and 14 g in the US; recommended daily
limits in these countries are 3–4 and 1–2 units, respectively) would be an
increase in systolic blood pressure of 0.24 mmHg.
What Do These Findings Mean? These findings support the suggestion
that alcohol has a marked effect on blood pressure and hypertension.
Consequently, some cases of hypertension could be prevented by
encouraging people to reduce their daily alcohol intake. Although the
Mendelian randomization approach avoids most of the confounding
intrinsic to observational studies, it is possible that a gene near ALDH2
that has no effect on alcohol intake affects blood pressure, since genes
are often inherited in blocks. Alternatively, ALDH2 could affect blood
pressure independent of alcohol intake. The possibility that ALDH2 could
effect blood pressure independently of alcohol is intake made unlikely by
the fact that no effect of genotype on blood pressure is seen among
women who drink very little. Additional large-scale studies are needed to
address these possibilities, to confirm the current finding in more people,
and to improve the estimates of the effect that alcohol intake has on
blood pressure.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050052.
  The MedlinePlus encyclopedia has a page on hypertension (in English
and Spanish)
  The American Heart Association provides information for patients and
health professionals about hypertension
  The UK Blood Pressure Association provides information for patients
and health professionals on all aspects of hypertension, including
information about alcohol affects blood pressure
  The Explore@Bristol science center (a UK charity) provides an alcohol
unit calculator and information on the effects of alcohol
  The International Center for Alcohol Policies provides drinking
guidelines for countries around the world
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